Cargando…

Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 – secondary analysis of a randomized controlled trial

BACKGROUND: Gestational diabetes mellitus (GDM) is characterized by disturbed glucose metabolism and activation of low-grade inflammation. We studied whether metformin treatment has favorable or unfavorable effects on inflammatory markers and insulin-like growth factor-binding protein 1 (IGFBP-1) in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huhtala, Mikael S., Tertti, Kristiina, Juhila, Juuso, Sorsa, Timo, Rönnemaa, Tapani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353798/ https://www.ncbi.nlm.nih.gov/pubmed/32652973 http://dx.doi.org/10.1186/s12884-020-03077-6

Ejemplares similares

Cord serum metabolome and birth weight in patients with gestational diabetes treated with metformin, insulin, or diet alone
por: Huhtala, Mikael S, et al.
Publicado: (2021)

Insulin Resistance Is Associated with an Unfavorable Serum Lipoprotein Lipid Profile in Women with Newly Diagnosed Gestational Diabetes
por: Huhtala, Mikael, et al.
Publicado: (2023)

Comparison of glucose metabolism and anthropometry in women with previous gestational diabetes treated with metformin vs. insulin: 9‐year follow‐up of two randomized trials
por: Huhtala, Mikael, et al.
Publicado: (2022)

Metformin Versus Insulin for Gestational Diabetes: Cognitive and Neuropsychological Profiles of Children Aged 9 years
por: Paavilainen, Elisa, et al.
Publicado: (2023)

Metformin versus insulin therapy for gestational diabetes: Effects on offspring anthropometrics and metabolism at the age of 9 years: A follow‐up study of two open‐label, randomized controlled trials
por: Paavilainen, Elisa, et al.
Publicado: (2021)

Corrigendum to “Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women” [Heliyon 6 (8) (August 2020) Article e04788]
por: Mokkala, Kati, et al.
Publicado: (2020)

Early pregnancy serum IGFBP-1 relates to lipid profile in overweight and obese women
por: Mokkala, Kati, et al.
Publicado: (2020)

Evaluation of serum zonulin for use as an early predictor for gestational diabetes
por: Mokkala, K, et al.
Publicado: (2017)

The Impacts of Fish Oil and/or Probiotic Intervention on Low-Grade Inflammation, IGFBP-1 and MMP-8 in Pregnancy: A Randomized, Placebo-Controlled, Double-Blind Clinical Trial
por: Houttu, Noora, et al.
Publicado: (2020)

Effects of insulin aspart and metformin on gestational diabetes mellitus and inflammatory markers
por: Wang, Yan, et al.
Publicado: (2023)

Metformin in Pregnancy Study (MiPS): protocol for a systematic review with individual patient data meta-analysis
por: Mousa, Aya, et al.
Publicado: (2020)

Amniotic Fluid Infection in Preterm Pregnancies with Intact Membranes
por: Myntti, Tarja, et al.
Publicado: (2017)

Starting bedtime glargine versus NPH insulin in poorly controlled type 2 diabetic patients with various hyperglycemia types (fasting type or postprandial type)
por: Vähätalo, Markku A., et al.
Publicado: (2013)

Could Metformin Manage Gestational Diabetes Mellitus instead of Insulin?
por: Saleh, Hend S., et al.
Publicado: (2016)

Maternal and Neonatal Circulating Markers of Metabolic and Cardiovascular Risk in the Metformin in Gestational Diabetes (MiG) Trial: Responses to maternal metformin versus insulin treatment
por: Barrett, Helen L., et al.
Publicado: (2013)

Metformin vs Insulin in the Management of Gestational Diabetes: A Meta-Analysis
por: Gui, Juan, et al.
Publicado: (2013)

Effect of insulin treatment on circulating insulin‐like growth factor I and IGF‐binding proteins in cats with diabetes mellitus
por: Strage, Emma M., et al.
Publicado: (2018)

IGF-I, IGF-II, and Insulin Stimulate Different Gene Expression Responses through Binding to the IGF-I Receptor
por: Versteyhe, Soetkin, et al.
Publicado: (2013)

Identification of insulin-like growth factor (IGF)-I and IGF-binding protein in chylous ascites.
por: Lee, D. Y.
Publicado: (1998)

Insulin-like growth factor (IGF)-I and IGF binding proteins axis in diabetes mellitus
por: Kim, Min Sun, et al.
Publicado: (2015)

Gestational Diabetes Mellitus and Energy-Dense Diet: What Is the Role of the Insulin/IGF Axis?
por: Martín-Estal, Irene, et al.
Publicado: (2022)

A healthy dietary pattern with a low inflammatory potential reduces the risk of gestational diabetes mellitus
por: Pajunen, Lotta, et al.
Publicado: (2021)

Analysis on the Effect of Metformin Hydrochloride Combined with Insulin Pump for Gestational Diabetes Mellitus
por: Li, Xinghua, et al.
Publicado: (2022)

Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
por: Lee, D. Y., et al.
Publicado: (1999)

Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis
por: Balsells, Montserrat, et al.
Publicado: (2015)

Feto-maternal outcomes and Glycemic control in Metformin versus insulin treated Gestational Diabetics
por: Arshad, Rabia, et al.
Publicado: (2017)

Metformin or insulin: logical treatment in women with gestational diabetes in the Middle East, our experience
por: Christian, Sindu J., et al.
Publicado: (2018)

Factors Associated with the Need for Insulin as a Complementary Treatment to Metformin in Gestational Diabetes Mellitus
por: Souza, Matheus Leite Ramos de, et al.
Publicado: (2019)

Insulin‐like Growth Factor (IGF)‐I, IGF‐binding Protein‐3 and Colorectal Adenomas in Japanese Men
por: Teramukai, Satoshi, et al.
Publicado: (2002)

Branched-Chain and Aromatic Amino Acids Are Predictors of Insulin Resistance in Young Adults
por: Würtz, Peter, et al.
Publicado: (2013)

Metformin in Gestational Diabetes Mellitus
por: Reece, Sara Wilson, et al.
Publicado: (2014)

Metformin in gestational diabetes mellitus
por: Tripathi, Reva, et al.
Publicado: (2017)

Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
por: Varewijck, A. J., et al.
Publicado: (2012)

Weight gain in infancy and markers of cardiometabolic health in young adulthood
por: Nummela, Saga Rebecca, et al.
Publicado: (2022)

Haplotypes of the imprinted insulin gene are associated with size for gestational age and umbilical cord IGF-II levels
por: Adkins, Ronald, et al.
Publicado: (2008)

Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer
por: Renehan, A G, et al.
Publicado: (2000)

Maternal obesity, gestational diabetes mellitus, and diet in association with neurodevelopment of 2-year-old children
por: Saros, Lotta, et al.
Publicado: (2023)

Maternal and Neonatal Outcomes in Pregnant Women with Gestational Diabetes Mellitus Treated with Diet, Metformin or Insulin
por: Simeonova-Krstevska, Slagjana, et al.
Publicado: (2018)

Effects of insulin and metformin on fetal kidney development of streptozotocin-induced gestational diabetic albino rats
por: Kassab, Ban M., et al.
Publicado: (2019)

Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation
por: Kiselyov, Vladislav V, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4ua5moavm38j8cgq66k3qrta4f